Subtotal integumentectomy for treatment of malignant melanoma with indocyanine green(ICG)
Phase 1
Recruiting
- Conditions
- malignant melanoma
- Registration Number
- JPRN-UMIN000035972
- Lead Sponsor
- Faculty of Life Sciences, Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects have a history of severe hypersensitivity and side effects in Indocyanine green (ICG). Subjects suffer from malignant tumors within 5 years. Subjects suffer from acute myocardial infarction, unstable angina, myocarditis, cerebral infarction within 3 months. Subjects have remarkably unstable circulation dynamics due to severe heart failure, arrhythmia, etc. Subject has active infection. Subjects may be pregnant or pregnant Subject's serum albumin is less than 2g/dl. We can not identify lymph flow with ICG during surgery. In addition, when the doctor in charge judges the subject as inappropriate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method